Response to: Comment on short- and long-term prognosis of glycemic control in COVID-19 patients with type 2 diabetes

QJM. 2022 Aug 13;115(8):569-570. doi: 10.1093/qjmed/hcac162.

K Zhan^{1

2}, X Zhang³, B Wang⁴, Z Jiang⁵, X Fang², S Yang⁶, H Jia¹, L Li⁷, G Cao⁷, K Zhang⁸, X Ma²

¹ From the College of Public Health, Southwest Medical University, Luzhou, Sichuan, China.
² Department of Epidemiology, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing, China.
³ Department of General Surgery, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
⁴ Pulmonary and Critical Care Medicine Center, Chinese PLA Respiratory Disease Institute, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
⁵ Yidu Cloud Technology Co. Ltd., Beijing, China.
⁶ Department of Infectious Diseases, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
⁷ Department of Respiratory Medicine, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
⁸ Department of Outpatients, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

No abstract available

Publication types